At FiE 2023, in Frankfurt, Germany, we sat down with Keiji Iga, the senior manager and head of business development Europe at Kyowa Hakko, to discuss its venture in human milk oligosaccharides (HMOs) production. He details the health benefits and versatility of 6’-Sialyllactose sodium salt and gives insights into the results of Kyowa Hakko’s recent novel food applications for 2’-Fucosyllactose and 3’-Sialyllactose sodium salt. We also explore the company’s plans for 2024.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients















